Cytek Aurora Spectral Analyser: essential investment to expand the Babraham Institute Flow Cytometry capabilities, enabling pioneering bioscience

Cytek Aurora 光谱分析仪:扩展 Babraham 研究所流式细胞术能力的必要投资,实现开创性的生物科学

基本信息

  • 批准号:
    BB/S019189/1
  • 负责人:
  • 金额:
    $ 41.97万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

The field of flow cytometry is essential in many areas of life science research, such as immunology, haematology, cell biology and cancer studies. At BI, we study healthy ageing and Flow Cytometry is an essential tool to do this. The Flow Cytometry Core Facility is a busy, successful facility housing state of the art cytometers that are supported by dedicated and experienced staff. The Flow Cytometry Core prides itself on providing excellent service to BI scientists (over 100 use the facility) and 17 bio-tech companies who are based at Babraham Research Campus. It is important that the equipment within the Flow Cytometry Facility is state-of-the-art to facilitate the pioneering science carried out by BI Scientists. There have been huge advances in the technology behind the flow cytometry instruments and the fluorochromes that are measured on the instruments and therefore it is important that BI Flow Cytometry Facility keeps up to date with these technology changes. One of the biggest recent changes in technology has been the introduction of spectral analysers. This equipment grant is for a Cytek Bioscience 5-laser Aurora Spectral Analyser to be housed within the BI Flow Cytometry Facility. The Cytek Bioscience Aurora Spectral Analyser (hereafter 'Aurora'), a new spectral analyser which looks at the spectra of fluorochromes across each of its 5 lasers. This technology has been used in the field of microscopy for years but is new to flow cytometry. The analysers currently within the Core can theoretically measure 27 fluorescent markers, however it is difficult to combine more than 20 markers together due to the lack of unique commercially available dyes and the challenges of using a number of markers in combination. The Aurora allows up to 50 fluorescent parameters to be used including combinations of dyes that are impossible in conventional flow cytometry. This means that fluorochromes with similar excitation and emission maximums can be used together in experiments. This ultimately enables scientists to look at more markers from a sample, allowing them to study individual cells in more detail, reducing the size of samples needed for analysis. Another challenge when studying cells using flow cytometry can be strong cellular autofluorescence which means it can be difficult to measure and quantify dim fluorescent markers. The Aurora measures autofluorescence as a separate parameter. Autofluorescence can then be subtracted from the fluorescence allowing scientists to detect and quantify dim fluorescent signals. Increasing the multicolour capabilities of the BI Flow Cytometry Core Facility is essential to continue the BI world-class science. The addition of an Aurora will strengthen the capabilities of the Flow Cytometry Core Facility, which will in turn help BI scientists with their bioscience research into lifelong health and wellbeing, particularly in the areas of ageing cell immunology and regenerative medicine. Cutting-edge flow cytometry capabilities also boost our connections with Babraham Research Campus and other scientists and maximises the value of the invested equipment funding.
流式细胞仪领域在生命科学研究的许多领域至关重要,例如免疫学,血液学,细胞生物学和癌症研究。在BI,我们研究健康的衰老和流式细胞仪是这样做的必要工具。流式细胞仪核心设施是一个繁忙,成功的设施住房状态,其最先进的细胞仪是由专门和经验丰富的员工支持的。流式细胞仪核心以为BA Babraham Research Campus的BAICOCICONS和17家​​生物技术公司提供出色的服务而自豪。重要的是,流式细胞仪设施中的设备是最先进的,以促进BI科学家进行的开创性科学。流式细胞仪仪器和在该仪器上测量的荧光色素的技术方面取得了巨大进步,因此,重要的是,BI流式细胞仪设施与这些技术变化保持最新状态非常重要。最近,技术最大的变化之一是引入光谱分析仪。该设备赠款是供Cytek Bioscience 5-laser Aurora光谱分析仪安装在BI流式细胞仪设施中的。 Cytek Bioscience Aurora光谱分析仪(以下称“ Aurora”),这是一种新的光谱分析仪,该分析仪着眼于其5个激光器中的每个激光器中的荧光色素光谱。多年来,该技术已在显微镜领域中使用,但对于流式细胞仪而言是新的。当前核心内的分析仪理论上可以测量27个荧光标记,但是由于缺乏独特的市售染料以及组合使用许多标记的挑战,很难将20多个标记组合在一起。 Aurora允许使用多达50个荧光参数,包括在常规流式细胞仪中不可能的染料组合。这意味着在实验中可以一起使用具有相似激发和发射最大值的荧光染料。这最终使科学家能够查看样本中的更多标记,使他们能够更详细地研究单个细胞,从而减少分析所需的样品的大小。 使用流式细胞仪研究细胞时的另一个挑战可能是强细胞自荧光,这意味着很难测量和量化昏暗的荧光标记。 Aurora将自动荧光作为单独参数测量。然后可以从荧光中减去自荧光,从而使科学家检测和量化昏暗的荧光信号。 提高BI流式细胞仪核心设施的多色功能对于继续BI世界一流的科学至关重要。 Aurora的添加将增强流式细胞仪核心设施的能力,这反过来将帮助BI科学家对终身健康和福祉的生物科学研究,尤其是在老化的细胞免疫学和再生医学领域。尖端流式细胞仪的能力还可以提高我们与Babraham研究校园和其他科学家的联系,并最大程度地提高投资设备资金的价值。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly.
  • DOI:
    10.1016/j.celrep.2023.112991
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    I. Ferreira;C. Q. Lee;W. Foster;A. Abdullahi;L. Dratva;Z. Tuong;B. Stewart;J. Ferdinand;Stephane M. Guillaume;Martin Potts;Marianne R Perera;Ben Krishna;Ana Ivis Peñalver;Mia Cabantous;S. Kemp;L. Ceron-Gutierrez;S. Ebrahimi;P. Lyons;Ken G. C. Smith;J. Bradley;D. Collier;L. McCoy;A. A. van der Klaauw-A.;James E. D. Thaventhiran;I. Farooqi;Sarah A. Teichmann;P. MacAry;R. Doffinger;M. Wills;M. Linterman;M. Clatworthy;Ravindra K. Gupta
  • 通讯作者:
    I. Ferreira;C. Q. Lee;W. Foster;A. Abdullahi;L. Dratva;Z. Tuong;B. Stewart;J. Ferdinand;Stephane M. Guillaume;Martin Potts;Marianne R Perera;Ben Krishna;Ana Ivis Peñalver;Mia Cabantous;S. Kemp;L. Ceron-Gutierrez;S. Ebrahimi;P. Lyons;Ken G. C. Smith;J. Bradley;D. Collier;L. McCoy;A. A. van der Klaauw-A.;James E. D. Thaventhiran;I. Farooqi;Sarah A. Teichmann;P. MacAry;R. Doffinger;M. Wills;M. Linterman;M. Clatworthy;Ravindra K. Gupta
AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data.
  • DOI:
    10.1038/s41467-021-23126-8
  • 发表时间:
    2021-05-17
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Roca CP;Burton OT;Gergelits V;Prezzemolo T;Whyte CE;Halpert R;Kreft Ł;Collier J;Botzki A;Spidlen J;Humblet-Baron S;Liston A
  • 通讯作者:
    Liston A
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
  • DOI:
    10.1016/j.xcrm.2022.100845
  • 发表时间:
    2022-12-20
  • 期刊:
  • 影响因子:
    14.3
  • 作者:
    Foster, William S.;Lee, Jia Le;Thakur, Nazia;Newman, Joseph;Spencer, Alexandra J.;Davies, Sophie;Woods, Danielle;Godfrey, Leila;Hay, Iain M.;Innocentin, Silvia;Yam-Puc, Juan Carlos;Horner, Emily C.;Sharpe, Hayley J.;Thaventhiran, James E.;Bailey, Dalan;Lambe, Teresa;Linterman, Michelle A.
  • 通讯作者:
    Linterman, Michelle A.
Do more with Less: Improving High Parameter Cytometry Through Overnight Staining.
  • DOI:
    10.1002/cpz1.589
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Whyte, Carly E.;Tumes, Damon J.;Liston, Adrian;Burton, Oliver T.
  • 通讯作者:
    Burton, Oliver T.
A Cross Entropy Test Allows Quantitative Statistical Comparison of t-SNE and UMAP Representations
交叉熵测试允许对 t-SNE 和 UMAP 表示进行定量统计比较
  • DOI:
    10.2139/ssrn.4189024
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Roca C
  • 通讯作者:
    Roca C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adrian Liston其他文献

Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency
  • DOI:
    10.1016/j.jaci.2014.10.010
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lien Van Eyck;Michael S. Hershfield;Diana Pombal;Susan J. Kelly;Nancy J. Ganson;Leen Moens;Glynis Frans;Heidi Schaballie;Gert De Hertogh;James Dooley;Xavier Bossuyt;Carine Wouters;Adrian Liston;Isabelle Meyts
  • 通讯作者:
    Isabelle Meyts
miR-29a maintains hematopoietic stem cell self-renewal and is required for leukemic transformation
  • DOI:
    10.1016/j.exphem.2013.05.170
  • 发表时间:
    2013-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Christopher Park;Wenhuo Hu;James Dooley;Stephen Chung;Yu Sup Shin;Bart De Strooper;Adrian Liston
  • 通讯作者:
    Adrian Liston
AutoSpill: a method for calculating spillover coefficients in high-parameter flow cytometry
AutoSpill:高参数流式细胞术中溢出系数的计算方法
  • DOI:
    10.17632/mtdww9hd3m.1
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Adrian Liston;Carlos P. Roca;Oliver T. Burton;Carly E. Whyte
  • 通讯作者:
    Carly E. Whyte
457 - Prospective Study Evaluating Predisposing Factors and Immune-Mediated Mechanisms Underlying Post-Infectious IBS
  • DOI:
    10.1016/s0016-5085(18)30791-1
  • 发表时间:
    2018-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Morgane Florens;Sander Van Wanrooy;Willy Peetermans;Mira M. Wouters;Winde Vanbrabant;James Dooley;Adrian Liston;Guy E. Boeckxstaens
  • 通讯作者:
    Guy E. Boeckxstaens
137: Altered Th1-Th2 response during infection is predictive for development of post-infectious Irritable Bowel Syndrome
  • DOI:
    10.1016/j.cyto.2014.07.144
  • 发表时间:
    2014-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anh T.L. Nguyen;Mira M. Wouters;Sander V. Wanrooy;James Dooley;Dina Danso-Abeam;Guy E. Boeckxstaens;Adrian Liston
  • 通讯作者:
    Adrian Liston

Adrian Liston的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adrian Liston', 18)}}的其他基金

Development of a humanised delivery system for interleukin 2 to treat traumatic brain injury
开发白细胞介素2人源化递送系统来治疗创伤性脑损伤
  • 批准号:
    MR/X029166/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Research Grant
Systemic analysis of the molecular mechanisms of leukocyte entry into the pancreas
白细胞进入胰腺分子机制的系统分析
  • 批准号:
    MR/T031395/1
  • 财政年份:
    2020
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Research Grant

相似国自然基金

基于时空谱联合的极光光谱图像点、面、体智能无损压缩算法研究
  • 批准号:
    62301429
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于陷光结构的透射式GaAs光电阴极光谱调制方法研究
  • 批准号:
    62271259
  • 批准年份:
    2022
  • 资助金额:
    53.00 万元
  • 项目类别:
    面上项目
基于陷光结构的透射式GaAs光电阴极光谱调制方法研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目
极光全辐射波段区域时变模型
  • 批准号:
    61775175
  • 批准年份:
    2017
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目
宽光谱响应半导体电极光电催化分解水稳定性的研究
  • 批准号:
    21573230
  • 批准年份:
    2015
  • 资助金额:
    67.0 万元
  • 项目类别:
    面上项目

相似海外基金

Aurora B複合体のセントロメア集合機構とその破綻が導く染色体不安定性
Aurora B复合体着丝粒组装机制及其破坏引起的染色体不稳定
  • 批准号:
    24KJ0996
  • 财政年份:
    2024
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
CAREER: Observational and Modeling Investigations of Pulsating Aurora Electrodynamics
职业:脉动极光电动力学的观测和建模研究
  • 批准号:
    2339961
  • 财政年份:
    2024
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Continuing Grant
Aurora Kinase を標的とした、卵巣癌の免疫療法抵抗性解除の可能性の探索
探索通过靶向极光激酶消除卵巢癌免疫治疗耐药性的可能性
  • 批准号:
    24K12553
  • 财政年份:
    2024
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aurora Aのユビキチン化リガーゼ活性を介したBRCA1関連分子の中心体制御機構の解明
通过Aurora A的泛素化连接酶活性阐明BRCA1相关分子的中心体控制机制
  • 批准号:
    23K14584
  • 财政年份:
    2023
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Aurora - transparent co-insurance for SMEs
Aurora - 为中小企业提供透明的共同保险
  • 批准号:
    10060843
  • 财政年份:
    2023
  • 资助金额:
    $ 41.97万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了